Measles

US gets another MMR vaccine option in GSK’s Priorix  

6 June 2022

GSK’s vaccine for the prevention of measles, mumps and rubella (MMR) has been approved by the US FDA, the company has announced.  The approval of GSK’s Priorix in the US gives patients another option for being vaccinated against MMR. The vaccine is already licensed in over 100 countries and more than 800 million doses have been […]

Global progress against measles threatened amidst Covid-19 pandemic  

16 November 2021

While reported measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a new report from the World Health Organization (WHO) and US Centers for Disease Control and Prevention (CDC).   During 2020, more than 22 million infants missed their first […]